133 related articles for article (PubMed ID: 9033847)
1. [Chronic hepatitis C: therapeutic uncertainties].
Blondon H; Bergmann JF
Gastroenterol Clin Biol; 1996; 20(12):1043-6. PubMed ID: 9033847
[No Abstract] [Full Text] [Related]
2. [Monitoring of treated or non-treated chronic viral hepatitis C. 2: Criteria of efficacy and monitoring of treatment with interferon-alpha].
Payen JL
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S175-89. PubMed ID: 9161529
[No Abstract] [Full Text] [Related]
3. [Results of treatment of hepatitis C with interferon alone or combined with other drugs].
Serfaty L
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S154-66. PubMed ID: 9161527
[No Abstract] [Full Text] [Related]
4. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
[TBL] [Abstract][Full Text] [Related]
5. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
Larrey D
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S99-110. PubMed ID: 9161521
[No Abstract] [Full Text] [Related]
6. [Should hepatitis C be treated? Which biological tests are useful before deciding or refuting a treatment with interferon-alpha in patients with chronic hepatitis C?].
Pawlotsky JM
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S41-50. PubMed ID: 9161513
[No Abstract] [Full Text] [Related]
7. Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-alpha therapy on clinical outcome and histological pattern.
Morosetti M; Sciarra G; Meloni C; Palmieri G; Palombo G; Taccone Gallucci M; Casciani CU
Nephrol Dial Transplant; 1996 Mar; 11(3):532-4. PubMed ID: 8671827
[No Abstract] [Full Text] [Related]
8. [Should hepatitis C be treated?].
Tran A
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S148-53. PubMed ID: 9161526
[No Abstract] [Full Text] [Related]
9. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
Marcellin P
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
[No Abstract] [Full Text] [Related]
10. [Should hepatitis C be treated? What are indications of treatment in chronic hepatitis C?].
Pascal JP
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S70-9. PubMed ID: 9161517
[No Abstract] [Full Text] [Related]
11. Clinical use of interferons in hepatology.
Civeira MP
Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():33-4. PubMed ID: 8899691
[No Abstract] [Full Text] [Related]
12. [Treatment of chronic hepatitis C. Many interrogatives and some answers].
Ampurdanès S; Rodés J
Rev Clin Esp; 1996 Oct; 196(10):667-9. PubMed ID: 9005467
[No Abstract] [Full Text] [Related]
13. [Disappointing response of chronic C hepatitis to interferon].
Theodor E; Regev A
Harefuah; 1997 Mar; 132(6):402-3, 447. PubMed ID: 9153855
[TBL] [Abstract][Full Text] [Related]
14. [How to follow treated and untreated chronic hepatitis B and C].
Adler M; Golstein P; Botembe N; Bourgeois N
Rev Med Brux; 1997 Sep; 18(4):183-6. PubMed ID: 9411639
[TBL] [Abstract][Full Text] [Related]
15. A rational approach to hepatitis C.
Mills P; McPeake J; McCruden E
Practitioner; 1996 Mar; 240(1560):172-6. PubMed ID: 8710731
[No Abstract] [Full Text] [Related]
16. [Treatment of chronic viral hepatitis].
Marcellin P; Metreau JM; Pol S; Zoulim F
Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
[No Abstract] [Full Text] [Related]
17. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
Tambini R; Quattrini A; Fracassetti O; Nemni R
J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
[No Abstract] [Full Text] [Related]
18. [Lichen planus and hepatitis C. Heterogeneity in the course of 6 cases treated with interferon alpha].
Doutre MS; Couzigou P; Beylot-Barry M; Beylot C; Quinton A
Gastroenterol Clin Biol; 1996; 20(8-9):709-10. PubMed ID: 8977825
[No Abstract] [Full Text] [Related]
19. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
Hopf U; Niederau C; Kleber G; Fleig WE
Z Gastroenterol; 1997 Nov; 35(11):971-86. PubMed ID: 9490556
[No Abstract] [Full Text] [Related]
20. Dose-finding study of interferon alfa-n3 in hepatitis C.
Hoofnagle JH; Everhart J
Hepatology; 1997 Nov; 26(5):1366-7. PubMed ID: 9362387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
